Yorktown Management & Research Co Inc acquired a new stake in Cantel Medical Corp. (NYSE:CMD) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 5,000 shares of the company’s stock, valued at approximately $471,000.
Several other institutional investors and hedge funds have also made changes to their positions in CMD. Capstone Asset Management Co. acquired a new position in shares of Cantel Medical in the 2nd quarter worth approximately $690,000. Bank of Montreal Can acquired a new position in Cantel Medical during the 2nd quarter worth $248,000. LS Investment Advisors LLC acquired a new position in Cantel Medical during the 2nd quarter worth $172,000. Nisa Investment Advisors LLC acquired a new position in Cantel Medical during the 2nd quarter worth $3,094,000. Finally, Louisiana State Employees Retirement System acquired a new position in Cantel Medical during the 2nd quarter worth $1,153,000. 84.98% of the stock is currently owned by institutional investors and hedge funds.
Cantel Medical Corp. (CMD) traded up $6.32 on Thursday, hitting $106.53. 300,811 shares of the company were exchanged, compared to its average volume of 147,127. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.49 and a current ratio of 2.41. Cantel Medical Corp. has a 1-year low of $69.21 and a 1-year high of $108.00. The company has a market cap of $4,450.00, a PE ratio of 48.31 and a beta of 1.24.
Cantel Medical (NYSE:CMD) last released its earnings results on Thursday, September 28th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.02. The firm had revenue of $205.50 million during the quarter, compared to analysts’ expectations of $200.32 million. Cantel Medical had a return on equity of 17.60% and a net margin of 9.27%. The business’s revenue for the quarter was up 14.8% on a year-over-year basis. research analysts predict that Cantel Medical Corp. will post 2.34 earnings per share for the current year.
The firm also recently disclosed a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Stockholders of record on Wednesday, January 17th will be paid a dividend of $0.085 per share. This represents a dividend yield of 0.17%. This is an increase from Cantel Medical’s previous Semi-Annual dividend of $0.07. The ex-dividend date is Tuesday, January 16th. Cantel Medical’s dividend payout ratio is currently 8.19%.
Separately, Needham & Company LLC reiterated a “hold” rating on shares of Cantel Medical in a research report on Friday, September 1st. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $91.67.
In related news, Director George L. Fotiades sold 6,000 shares of the firm’s stock in a transaction dated Friday, October 13th. The shares were sold at an average price of $95.23, for a total value of $571,380.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Eric W. Nodiff sold 2,868 shares of the firm’s stock in a transaction that occurred on Friday, October 20th. The stock was sold at an average price of $97.55, for a total transaction of $279,773.40. Following the sale, the executive vice president now owns 39,102 shares of the company’s stock, valued at $3,814,400.10. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 36,368 shares of company stock valued at $3,576,028. Company insiders own 12.30% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This article was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2017/12/08/5000-shares-in-cantel-medical-corp-cmd-acquired-by-yorktown-management-research-co-inc.html.
Cantel Medical Company Profile
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.